Express Pharma - Page 11 of 2164 - Express Pharma

The invisible threat: Why packaging inks are the next major recall risk for pharma

Advanced excipients: India’s gate to high-value drug formulation

Rx Propellant appoints Ashish Singh as CEO and MD

Supriya Lifescience ramps up capacity and global readiness for next phase of growth

Sharp Sterile Manufacturing increases capacity with $28 million investment

We are cost-competitive and aligned with global ESG framework demands

Sigachi Industries appoints Atul Dhavle as Chief People Officer

Separate license regime for bulk drugs, API and KSMs, under govt’s consideration

Dr. Reddy’s launches Hevaxin, a novel recombinant Hepatitis E vaccine in India

Leadership imperative shaping India’s healthcare and pharma landscape in 2026

Advanced excipients could emerge as India’s next big pharma advantage

Pandorum Technologies, Nucelion Therapeutics partner to manufacture exosome-based therapy for ocular diseases in APAC markets

Under amended guidelines, pharma firms may no longer have to appear in courts for ‘minor contraventions’